Literature DB >> 18523251

Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation.

Yong-Jiu Jin1, Catherine Yi Cai, Xiaoping Zhang, Steven J Burakoff.   

Abstract

Nef is a HIV-1 accessory protein critical for the replication of the virus and the development of AIDS. The major pathological activity of Nef is the down-regulation of CD4, the primary receptor of HIV-1 infection. The mechanism underlying Nef-mediated CD4 endocytosis and degradation remains incompletely understood. Since protein ubiquitination is the predominant sorting signal in receptor endocytosis, we investigated whether Nef is ubiquitinated. The in vivo ubiquitination assay showed that both HIV-1 and SIV Nef proteins expressed in Jurkat T cells and 293T cells were multiple ubiquitinated by ubiquitin-His. The lysine-free HIV-1 Nef mutant (Delta10K) generated by replacing all 10 lysines with arginines was not ubiquitinated and the major ubiquitin-His attachment sites in HIV-1 Nef were determined to be lysine 144 (di-ubiquitinated) and lysine 204 (mono-ubiquitinated). Lysine-free HIV-1 Nef was completely inactive in Nef-mediated CD4 down-regulation, so was the Nef mutant with a single arginine substitution at K144 but not at K204. A mutant HIV-1 provirion NL4-3 with a single arginine substitution in Nef at K144 was also inactive in Nef-mediated CD4 down-regulation. Lysine-free Nef mutant reintroduced with lysine 144 (DeltaK10 + K144) was shown active in CD4 down-regulation. These data suggest that ubiquitination of Nef, particularly diubiquitination of the lysine 144, is necessary for Nef-mediated CD4 down-regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523251     DOI: 10.4049/jimmunol.180.12.7878

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  AP-2 Is the Crucial Clathrin Adaptor Protein for CD4 Downmodulation by HIV-1 Nef in Infected Primary CD4+ T Cells.

Authors:  Marcos Vinicius Gondim; Linda Wiltzer-Bach; Brigitte Maurer; Carina Banning; Enrique Arganaraz; Michael Schindler
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Authors:  Nadine Laguette; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

3.  Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1.

Authors:  Art F Y Poon; Luke C Swenson; Winnie W Y Dong; Wenjie Deng; Sergei L Kosakovsky Pond; Zabrina L Brumme; James I Mullins; Douglas D Richman; P Richard Harrigan; Simon D W Frost
Journal:  Mol Biol Evol       Date:  2009-12-02       Impact factor: 16.240

4.  Ubiquitin ligase Nedd4-2 modulates Kv1.3 current amplitude and ion channel protein targeting.

Authors:  Patricio Vélez; Austin B Schwartz; Subashini R Iyer; Anthony Warrington; Debra Ann Fadool
Journal:  J Neurophysiol       Date:  2016-05-04       Impact factor: 2.714

5.  Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.

Authors:  Andrey Tokarev; John Guatelli
Journal:  Cell Logist       Date:  2011-05

6.  Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux.

Authors:  Bela F Asztalos; Zahedi Mujawar; Matthew P Morrow; Angela Grant; Tatiana Pushkarsky; Christine Wanke; Richard Shannon; Matthias Geyer; Frank Kirchhoff; Dmitri Sviridov; Michael L Fitzgerald; Michael Bukrinsky; Keith G Mansfield
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

7.  Alkylating HIV-1 Nef - a potential way of HIV intervention.

Authors:  Yong-Jiu Jin; Xiaoping Zhang; Catherine Yi Cai; Steven J Burakoff
Journal:  AIDS Res Ther       Date:  2010-07-26       Impact factor: 2.250

8.  Human immunodeficiency virus type 1 Nef protein targets CD4 to the multivesicular body pathway.

Authors:  Luis L P daSilva; Rachid Sougrat; Patricia V Burgos; Katy Janvier; Rafael Mattera; Juan S Bonifacino
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

9.  HIV-1 Vpr redirects host ubiquitination pathway.

Authors:  Sakshi Arora; Sachin Verma; Akhil C Banerjea
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

Review 10.  HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy.

Authors:  Susanna L Lamers; Gary B Fogel; David J Nolan; Michael S McGrath; Marco Salemi
Journal:  Biosystems       Date:  2014-04-13       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.